• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨曲南、黏菌素以及氨曲南、头孢他啶和阿米卡星三联药物对产金属β-内酰胺酶铜绿假单胞菌的体外抗菌作用。

In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.

作者信息

Oie Shigeharu, Fukui Yumi, Yamamoto Masaya, Masuda Yuki, Kamiya Akira

机构信息

Department of Pharmacy, Yamaguchi University Hospital, Ube, Japan.

出版信息

BMC Infect Dis. 2009 Aug 10;9:123. doi: 10.1186/1471-2334-9-123.

DOI:10.1186/1471-2334-9-123
PMID:19664245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2738676/
Abstract

BACKGROUND

There are limited choice of antimicrobial agents to treat infection with metallo-beta-lactamase-producing Pseudomonas aeruginosa. We evaluate the antimicrobial effects of aztreonam alone, colistin alone and the 3-drug combination of aztreonam, ceftazidime and amikacin on 23 strains of metallo-beta-lactamase-producing P. aeruginosa by time-killing tests.

METHODS

Strains used were from different hospitals in Japan and had different pulse-field gel electrophoresis patterns by restriction with SpeI. The minimum inhibitory concentrations of 11 antimicrobial agents (piperacillin, piperacillin/tazobactam, imipenem, meropenem, aztreonam, ceftazidime, amikacin, tobramycin, arbekacin, ciprofloxacin and colistin) were determined using the agar dilution test. The effects of aztreonam, colistin and the combination of aztreonam, ceftazidime and amikacin were determined by time-killing studies.

RESULTS

Bacteriostatic effects after 6 hours of drug exposure were observed in 12 strains (52.2%) of 23 strains of metallo-beta-lactamase-producing P. aeruginosa with 48 mg/l aztreonam, in 19 strains (82.6%) with the 3-drug combination of 16 mg/l aztreonam, 16 mg/l ceftazidime, and 4 mg/l amikacin, and in 23 strains (100%) with 2 mg/l colistin. Bactericidal effects after 6 h drug exposure were observed in 1 strain (4.3%) with 48 mg/l aztreonam, in 8 strains (30.4%) with the 3-drug combination and in all 23 strains (100%) with 2 mg/l colistin.

CONCLUSION

Evaluation of in vitro antimicrobial effects on metallo-beta-lactamase-producing P. aeruginosa revealed relatively good effects of the 3-drug combination of aztreonam, ceftazidime and amikacin and marked effects of colistin.

摘要

背景

治疗产金属β-内酰胺酶的铜绿假单胞菌感染时,抗菌药物的选择有限。我们通过时间杀菌试验评估了氨曲南单独使用、多黏菌素单独使用以及氨曲南、头孢他啶和阿米卡星三联用药对23株产金属β-内酰胺酶的铜绿假单胞菌的抗菌效果。

方法

所用菌株来自日本不同医院,经SpeI酶切后具有不同的脉冲场凝胶电泳图谱。采用琼脂稀释法测定11种抗菌药物(哌拉西林、哌拉西林/他唑巴坦、亚胺培南、美罗培南、氨曲南、头孢他啶、阿米卡星、妥布霉素、阿贝卡星、环丙沙星和多黏菌素)的最低抑菌浓度。通过时间杀菌研究确定氨曲南、多黏菌素以及氨曲南、头孢他啶和阿米卡星联合用药的效果。

结果

在23株产金属β-内酰胺酶的铜绿假单胞菌中,12株(52.2%)在接触48mg/L氨曲南6小时后出现抑菌效果,19株(82.6%)在接触16mg/L氨曲南、16mg/L头孢他啶和4mg/L阿米卡星的三联用药后出现抑菌效果,23株(100%)在接触2mg/L多黏菌素后出现抑菌效果。1株(4.3%)在接触48mg/L氨曲南6小时后出现杀菌效果,8株(30.4%)在三联用药后出现杀菌效果,所有23株(100%)在接触2mg/L多黏菌素后出现杀菌效果。

结论

对产金属β-内酰胺酶的铜绿假单胞菌的体外抗菌效果评估显示,氨曲南、头孢他啶和阿米卡星三联用药效果相对较好,多黏菌素效果显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/2738676/14a4abb459a7/1471-2334-9-123-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/2738676/6581ce7cb231/1471-2334-9-123-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/2738676/abe5420a10c5/1471-2334-9-123-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/2738676/14a4abb459a7/1471-2334-9-123-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/2738676/6581ce7cb231/1471-2334-9-123-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/2738676/abe5420a10c5/1471-2334-9-123-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/2738676/14a4abb459a7/1471-2334-9-123-3.jpg

相似文献

1
In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.氨曲南、黏菌素以及氨曲南、头孢他啶和阿米卡星三联药物对产金属β-内酰胺酶铜绿假单胞菌的体外抗菌作用。
BMC Infect Dis. 2009 Aug 10;9:123. doi: 10.1186/1471-2334-9-123.
2
In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.新型β-内酰胺酶抑制剂他尼硼巴坦与头孢吡肟或美罗培南对肺炎克雷伯菌的体外比较活性以及头孢吡肟对产金属β-内酰胺酶的铜绿假单胞菌临床分离株的体外比较活性。
Int J Antimicrob Agents. 2021 Nov;58(5):106440. doi: 10.1016/j.ijantimicag.2021.106440. Epub 2021 Sep 20.
3
In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).临床呼吸道分离株对头孢他啶-阿维巴坦及对照药物的体外抗菌敏感性(2016 - 2018年)
BMC Infect Dis. 2021 Jun 23;21(1):600. doi: 10.1186/s12879-021-06153-0.
4
Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.含头孢他啶-阿维巴坦的抗生素组合对广泛耐药铜绿假单胞菌的时间杀菌评估及其对头孢他啶-阿维巴坦耐药分离株的潜在作用。
Microbiol Spectr. 2021 Sep 3;9(1):e0058521. doi: 10.1128/Spectrum.00585-21. Epub 2021 Jul 28.
5
Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.评价头孢他啶-阿维巴坦与美罗培南、阿米卡星、氨曲南、黏菌素或磷霉素联合使用对经过充分特征鉴定的多药耐药肺炎克雷伯菌和铜绿假单胞菌的协同作用。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00779-19. Print 2019 Aug.
6
Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa.药物对多重耐药铜绿假单胞菌的抗菌作用。
Biol Pharm Bull. 2008 Oct;31(10):1898-901. doi: 10.1248/bpb.31.1898.
7
In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.抗假单胞菌药物组合对七株多重耐药铜绿假单胞菌的体外作用
J Antimicrob Chemother. 2003 Dec;52(6):911-4. doi: 10.1093/jac/dkg478. Epub 2003 Oct 29.
8
In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.多种抗生素单独及与阿米卡星联合使用对铜绿假单胞菌的体外活性。
J Antimicrob Chemother. 1995 Oct;36(4):707-11. doi: 10.1093/jac/36.4.707.
9
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.由一株产PER-1超广谱β-内酰胺酶的铜绿假单胞菌引起的大鼠实验性肺炎的治疗。
J Antimicrob Chemother. 1999 Jul;44(1):91-7. doi: 10.1093/jac/44.1.91.
10
[Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].[耐头孢他啶铜绿假单胞菌分离株中β-内酰胺酶的分子流行病学]
Mikrobiyol Bul. 2015 Apr;49(2):156-65. doi: 10.5578/mb.8901.

引用本文的文献

1
Antibacterial and Anti-Efflux Activities of Cinnamon Essential Oil against Pan and Extensive Drug-Resistant Isolated from Human and Animal Sources.肉桂精油对从人和动物源分离出的泛耐药及广泛耐药菌的抗菌和抗外排活性
Antibiotics (Basel). 2023 Oct 5;12(10):1514. doi: 10.3390/antibiotics12101514.
2
Biodiversity of Skin Microbiota as an Important Biomarker for Wound Healing.皮肤微生物群的生物多样性作为伤口愈合的重要生物标志物
Biology (Basel). 2023 Aug 30;12(9):1187. doi: 10.3390/biology12091187.
3
Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.

本文引用的文献

1
Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa.药物对多重耐药铜绿假单胞菌的抗菌作用。
Biol Pharm Bull. 2008 Oct;31(10):1898-901. doi: 10.1248/bpb.31.1898.
2
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.1993年至2004年间美国重症监护病房患者中引起感染的革兰氏阴性杆菌的抗菌药物耐药性。
J Clin Microbiol. 2007 Oct;45(10):3352-9. doi: 10.1128/JCM.01284-07. Epub 2007 Aug 22.
3
Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram.
烧伤患者分离的铜绿假单胞菌的抗生素耐药谱特征。
Burns. 2021 Dec;47(8):1833-1843. doi: 10.1016/j.burns.2021.03.005. Epub 2021 Mar 17.
4
Emergence of antibiotic resistance in intensive care unit; a critical review.重症监护病房中抗生素耐药性的出现;一项批判性综述。
Genes Dis. 2019 Apr 17;6(2):109-119. doi: 10.1016/j.gendis.2019.04.001. eCollection 2019 Jun.
5
Carbapenem Resistance in Non-Fermentative Bacterial Species and in Enterobacteriaceae Isolates from Hospitalized Patients in Different Health-Care Settings.不同医疗环境下住院患者非发酵菌及肠杆菌科分离株对碳青霉烯类抗生素的耐药性
Clujul Med. 2014;87(4):235-41. doi: 10.15386/cjmed-282. Epub 2014 Nov 12.
6
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.一项为期 18 个月的研究,旨在评估重复使用吸入性阿佐霉素赖氨酸治疗囊性纤维化的安全性和疗效。
Pediatr Pulmonol. 2010 Nov;45(11):1121-34. doi: 10.1002/ppul.21301.
铜绿假单胞菌感染经验性双重抗菌治疗最佳组合的鉴定:联合药敏试验的潜在作用
Infect Control Hosp Epidemiol. 2006 Apr;27(4):413-5. doi: 10.1086/503175. Epub 2006 Mar 17.
4
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
5
Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.多重耐药铜绿假单胞菌引起的严重感染的治疗与控制
Clin Microbiol Infect. 2005 Jul;11 Suppl 4:17-32. doi: 10.1111/j.1469-0691.2005.01161.x.
6
Metallo-beta-lactamases: the quiet before the storm?金属β-内酰胺酶:暴风雨前的宁静?
Clin Microbiol Rev. 2005 Apr;18(2):306-25. doi: 10.1128/CMR.18.2.306-325.2005.
7
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.抗菌药物联合使用对多重耐药铜绿假单胞菌的抗生素后效应
Diagn Microbiol Infect Dis. 2005 Feb;51(2):113-7. doi: 10.1016/j.diagmicrobio.2004.09.004.
8
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.多粘菌素在治疗多重耐药革兰氏阴性菌感染中的应用。
Am J Health Syst Pharm. 2005 Jan 1;62(1):39-47. doi: 10.1093/ajhp/62.1.39.
9
Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.左氧氟沙星和环丙沙星与头孢吡肟、头孢他啶、亚胺培南、哌拉西林-他唑巴坦及阿米卡星联合应用对不同表型铜绿假单胞菌和不动杆菌属的抗菌活性
Chemotherapy. 2004 Oct;50(4):202-10. doi: 10.1159/000081033. Epub 2004 Sep 23.
10
In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.抗生素组合对铜绿假单胞菌临床分离株的体外活性
Kaohsiung J Med Sci. 2004 Jun;20(6):261-7. doi: 10.1016/s1607-551x(09)70116-0.